American Century Companies Inc Relay Therapeutics, Inc. Transaction History

American Century Companies Inc

$188 Billion
Q3 2025

A detailed history of American Century Companies Inc transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 393,704 shares of RLAY stock, worth $2.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

393,704

Previous 349,420 12.67%

Holding current value

$2.61 Million

Previous $1.21 Million 70.12%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$3.22 - $5.22 $142,594 - $231,162	44,284 Added 12.67%	393,704 $2.06 Million
Q2 2025 Aug 12, 2025	BUY	$2.0 - $3.49 $81,336 - $141,931	40,668 Added 13.17%	349,420 $1.21 Million
Q1 2025 May 13, 2025	BUY	$2.62 - $4.92 $95,855 - $180,003	36,586 Added 13.44%	308,752 $808,000
Q4 2024 Feb 11, 2025	BUY	$4.12 - $6.8 $212,175 - $350,193	51,499 Added 23.34%	272,166 $1.12 Million
Q3 2024 Nov 12, 2024	BUY	$6.23 - $9.51 $265,267 - $404,926	42,579 Added 23.91%	220,667 $1.56 Million

Q2 2024 Aug 07, 2024	BUY	$5.9 - $8.02 $170,474 - $231,729	28,894 Added 19.37%	178,088 $1.16 Million
Q1 2024 May 14, 2024	BUY	$7.5 - $12.07 $464,415 - $747,398	61,922 Added 70.95%	149,194 $1.24 Million
Q4 2023 Feb 13, 2024	BUY	$6.01 - $11.48 $524,504 - $1 Million	87,272 New	87,272 $960,000
Q3 2023 Nov 13, 2023	BUY	$8.24 - $12.97 $170,180 - $267,869	20,653 Added 5.68%	384,536 $3.23 Million
Q2 2023 Aug 14, 2023	BUY	$9.99 - $18.27 $1.23 Million - $2.26 Million	123,502 Added 51.38%	363,883 $4.57 Million
Q1 2023 May 11, 2023	BUY	$15.0 - $22.76 $315,240 - $478,324	21,016 Added 9.58%	240,381 $3.96 Million
Q4 2022 Feb 13, 2023	BUY	$14.16 - $24.02 $4,672 - $7,926	330 Added 0.15%	219,365 $3.28 Million
Q3 2022 Nov 14, 2022	SELL	$18.07 - $31.37 $37,025 - $64,277	-2,049 Reduced 0.93%	219,035 $4.9 Million
Q2 2022 Aug 12, 2022	BUY	$13.31 - $34.88 $215,635 - $565,090	16,201 Added 7.91%	221,084 $3.7 Million
Q1 2022 May 11, 2022	BUY	$20.26 - $32.36 $1,235 - $1,973	61 Added 0.03%	204,883 $6.13 Million
Q4 2021 Feb 07, 2022	BUY	$26.0 - $37.03 $175,630 - $250,137	6,755 Added 3.41%	204,822 $6.29 Million
Q3 2021 Nov 10, 2021	BUY	$29.75 - $37.99 $1,874 - $2,393	63 Added 0.03%	198,067 $6.25 Million
Q2 2021 Aug 05, 2021	BUY	$27.5 - $38.19 $2.3 Million - $3.19 Million	83,619 Added 73.1%	198,004 $7.25 Million
Q1 2021 May 14, 2021	SELL	$32.52 - $61.53 $61,462 - $116,291	-1,890 Reduced 1.63%	114,385 $3.95 Million
Q4 2020 Feb 12, 2021	SELL	$35.51 - $54.03 $258,335 - $393,068	-7,275 Reduced 5.89%	116,275 $4.83 Million
Q3 2020 Nov 13, 2020	BUY	$32.81 - $45.1 $4.05 Million - $5.57 Million	123,550 New	123,550 $5.26 Million

Others Institutions Holding RLAY

# of Institutions

216

Shares Held

168M

Call Options Held

714K

Put Options Held

14.9K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $796M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Relay Therapeutics, Inc. Transaction History